Clinical Trials Directory

Trials / Completed

CompletedNCT02582151

Transcutaneous Peripheral Neuromodulation for Neurogenic Bladder

A Randomized Trial of Transcutaneous Nerve Stimulation for Neurogenic Bladder

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Neurogenic bladder patients may have symptoms of urinary frequency, urgency, urgency incontinence and voiding symptoms due to bladder dysfunction arising from their underlying neurologic condition. Current treatment options are effective for some patients, however many patients are not optimally managed due to modest efficacy or significant side effects. Second line therapies include intravesical onabotulinum toxin, however it is associated with a risk of urinary retention, and patients with neurologic disorders often are unable to perform self catheterize due to physical limitations. Sacral neuromodulation is associated with an undesirably high cost and potential complications in this population. The use of transcutaneous tibial nerve stimulation is an alternative form of neuromodulation, and it may have some potential benefits over percutaneous tibial nerve stimulation. While some preliminary studies have suggested it may be effective, there are no high quality randomized trials. This proposal is a 3 month, randomized, sham-controlled, clinical trial to evaluate the short term clinical efficacy of at home transcutaneous tibial nerve stimulation. Valid and reliable patient reported outcome measures, and objective measures of incontinence have been included as outcomes.

Conditions

Interventions

TypeNameDescription
DEVICEEV-906 Digital Transcutaneous electrical nerve stimulation (TENS) machinePercutaneous patch electrodes are used to deliver low level electrical currents.

Timeline

Start date
2016-01-01
Primary completion
2019-03-01
Completion
2019-04-01
First posted
2015-10-21
Last updated
2020-01-09
Results posted
2020-01-09

Source: ClinicalTrials.gov record NCT02582151. Inclusion in this directory is not an endorsement.

Transcutaneous Peripheral Neuromodulation for Neurogenic Bladder (NCT02582151) · Clinical Trials Directory